Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 1919-1925

  Li, Xiayu ^a   Li, Heng ^a   Chen, Jianghua ^a,b   He, Qiang ^a   Lv, Rong ^a   Lin, Weiqin ^a   Li, Qun ^a   He, Xuelin ^a   Qu, Lihui ^a   Suya, Wang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adults; Intravenous cyclophosphamide; Minimal change nephrotic syndrome; Steroid dependence; Tacrolimus

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; INFECTION; LEUKOPENIA; LIVER TOXICITY; MALE; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; CHI-SQUARE DISTRIBUTION; CHINA; CREATININE; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PROBABILITY; PROTEINURIA; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TACROLIMUS; TREATMENT OUTCOME;

EID: 44449179874     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm637     Document Type: Article

References (20)

1. Inoue Y, Iijima K, Nakamura H et al. Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 1999; 13: 33-38
2. Prasad N, Gulati S, Sharma PK et al. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 2004; 19: 494-498
3. Ponticelli C, Edefonti A, Ghio L et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332
4. Bagga A, Hari P, Moudgil A et al. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 2003; 42: 1114-1120
5. Huang JJ, Hsu SC, Chen FF et al. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis. Am J Nephrol 2001; 21: 28-34
6. Gauthier B, Trachtman H. Pharmacological treatment of nephrotic syndrome. Drugs Today (Barc) 1999; 35: 13-26
7. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16: 271-282
8. El-Husseini A, El-Basuony F, Mahmoud I et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 2005; 20: 2433-2438
9. Chamienia A, Biedunkiewicz B, Krol E et al. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. Transplant Proc 2006; 38: 81-85
10. Falkiewicz K, Kaninska D, Nahaczewska W et al. Renal function and tubular phosphate handling in long-term cyclosporineand tacrolimus-based immunosuppression in kidney transplantation. Transplant Proc 2006; 38: 119-122
11. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353: 1083-1091
12. Westhoff TH , Schmidt S, Zidek W et al. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol 2006; 65: 393-400
13. Segarra A, Vila J, Pou L et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002; 17: 655-662
14. Loeffler K, Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol 2004; 19: 281-287
15. Sinha MD, Macleod R, Rigby E et al. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant 2006; 21: 1848-1854
16. Maruyama K, Tomizawa S, Seki Y et al. FK506 for vascular permeability factor production in minimal change nephrotic syndrome. Nephron 1994; 66: 486-487
17. Fujinaga S, Ohtomo Y, Umino D et al. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 2007; 22: 71-76
18. Ulinski T, Dubourg L, Said MH et al. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol 2005; 20: 482-485
19. Mendizabal S, Zamora I, Berbel O et al. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 2005; 20: 914-919
20. Kobashigawa JA, Patel J, Furukawa H et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 2006; 25: 434-439